ÂÜÀòÂÒÂ×

Safa Nada holds extensive experience in the pharmaceutical sector, currently serving as a Marketing Materials and Media Monitoring Reviewer at EDA since October 2020. Concurrently, Safa is a member of the Non-Reference Scientific Committee at the Egyptian Drug Authority, responsible for providing comprehensive evaluations of proposed drug products. Previously, Safa worked as a Drug Development Scientific Committee officer at the Egyptian Drug Authority (CAPA), where the focus included reviewing unreferenced dosage forms and conducting comparative analyses. Additionally, Safa has a significant background in clinical pharmacy, having contributed to national initiatives such as the establishment of the National Medication Errors Reporting System and serving in various leadership roles in clinical pharmacy projects. Education includes a degree in Pharmacy and Biotechnology from the German University in Cairo, along with certification as an American Board of Pharmacotherapy Specialist. Key achievements include the successful establishment of critical appraisal tools for clinical trials and medication error reporting initiatives utilized across Egyptian governmental hospitals.